APP and Alzheimer disease: The NGF metabolic dysregulation has also been replicated in the brain of transgenic rodent models of the human AD-like amyloid pathology [98,129,130] as well as in the Ts65Dn mouse model of DS [108], a model displaying increased APP protein and transcript levels [131,132,133,134,135,136,137,138].